会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 131. 发明申请
    • Method and System for Object Detection Using Probabilistic Boosting Cascade Tree
    • 使用概率提升级联树的对象检测方法和系统
    • US20080071711A1
    • 2008-03-20
    • US11856109
    • 2007-09-17
    • Wei ZhangAdrian BarbuYefeng ZhengDorin Comaniciu
    • Wei ZhangAdrian BarbuYefeng ZhengDorin Comaniciu
    • G06F15/18
    • G06N7/005G06K9/6257G06K2209/053
    • A method and system for object detection using a probabilistic boosting cascade tree (PBCT) is disclosed. A PBCT is a machine learning based classifier having a structure that is driven by training data and determined during the training process without user input. In a PBCT training method, for each node in the PBCT, a classifier is trained for the node based on training data received at the node. The performance of the classifier trained for the node is then evaluated based on the training data. Based on the performance of the classifier, the node is set to either a cascade node or a tree node. If the performance indicates that the data is relatively easy to classify, the node can be set as a cascade node. If the performance indicates that the data is relatively difficult to classify, the node can be set as a tree node. The trained PBCT can then be used to detect objects or classify data. For example, a trained PBCT can be used to detect lymph nodes in CT volume data.
    • 公开了一种使用概率升压级联树(PBCT)进行物体检测的方法和系统。 PBCT是基于机器学习的分类器,其具有由训练数据驱动的结构,并且在训练过程中确定而不需要用户输入。 在PBCT训练方法中,对于PBCT中的每个节点,基于在节点处接收到的训练数据,为节点训练分类器。 然后根据训练数据对针对节点训练的分类器的性能进行评估。 基于分类器的性能,将节点设置为级联节点或树节点。 如果性能指示数据相对容易分类,则可以将节点设置为级联节点。 如果性能指示数据相对较难分类,则可以将节点设置为树节点。 然后,训练有素的PBCT可用于检测对象或对数据进行分类。 例如,训练有素的PBCT可用于检测CT体积数据中的淋巴结。
    • 136. 发明申请
    • Method for synchronizing contact information
    • 联系信息同步方法
    • US20070189501A1
    • 2007-08-16
    • US11653994
    • 2007-01-17
    • Cheng-Shing LaiWei Zhang
    • Cheng-Shing LaiWei Zhang
    • H04M1/00H04M3/00
    • H04M1/274516
    • A method for synchronizing the contact information, which is applied in the synchronization between a wireless exchange device and a communication device. Both the wireless exchange devices and the communication devices have a synchronization software, respectively. The synchronization software allows the wireless exchange device and the communication device to be set as a transmitter or a receiver interchangeably, and it also allows a keyword searching, multiple entries, or the entire database of contact information to be sent from the transmitter to the receiver. In addition, the synchronization software also provides a verification process to ensure the contact information is only sent to the authorized device. Therefore, the receiver can obtain the contact information stored in a contact database of the transmitter, thus achieving the aim of updating the contact databases.
    • 一种用于同步在无线交换装置和通信装置之间的同步中应用的联系人信息的方法。 无线交换设备和通信设备分别具有同步软件。 同步软件允许无线交换设备和通信设备可互换地设置为发送器或接收器,并且还允许将关键字搜索,多个条目或整个联系人信息数据库从发送器发送到接收器 。 此外,同步软件还提供验证过程,以确保联系人信息仅发送到授权设备。 因此,接收机可以获得存储在发射机的联系人数据库中的联系信息,从而达到更新联系人数据库的目的。
    • 139. 发明申请
    • Method and system for fiber tracking
    • 光纤跟踪方法及系统
    • US20070124117A1
    • 2007-05-31
    • US11336376
    • 2006-01-20
    • Wei Zhang
    • Wei Zhang
    • G06F15/00
    • G01R33/56341G01R33/546G01R33/5608
    • One embodiment of the present invention includes a system comprising to determine a direction of tracking a fiber based on a vector corresponding to a largest value of a set of values for a tensor, if an anisotropy value of the tensor is greater than or equal to a first threshold; and to apply a weighted function to the vector of the tensor to select the direction of tracking the fiber, if the anisotropy value of the tensor is less than or equal to the first threshold and larger than or equal to a second threshold. In one embodiment, the system is to generate the weighted function comprises a linear interpolation to be performed on the vector. In one embodiment, a weight of the linear interpolation is in part dependent on the anisotropy value of the tensor, wherein the weight corresponds to the anisotropy value relative to the first threshold. One embodiment of the invention is also executable as a method
    • 本发明的一个实施例包括一种系统,包括:如果张量的各向异性值大于或等于a,则确定基于与张量的一组值的最大值对应的矢量来跟踪光纤的方向 第一门槛; 并且如果张量的各向异性值小于或等于第一阈值且大于或等于第二阈值,则将加权函数应用于张量的向量以选择跟踪光纤的方向。 在一个实施例中,系统是生成加权函数,包括要对向量执行的线性内插。 在一个实施例中,线性内插的权重部分地取决于张量的各向异性值,其中权重对应于相对于第一阈值的各向异性值。 本发明的一个实施例也可以作为一种方法执行
    • 140. 发明申请
    • Immunoconjugate formulations
    • 免疫缀合物制剂
    • US20070031402A1
    • 2007-02-08
    • US11498139
    • 2006-08-03
    • Wei ZhangMichael FlemingGodfrey AmphlettHung-wei ChihElizabeth Bartlett
    • Wei ZhangMichael FlemingGodfrey AmphlettHung-wei ChihElizabeth Bartlett
    • A61K39/395
    • A61K47/48561A61K9/0019A61K47/10A61K47/26A61K47/40A61K47/6803A61K47/6849A61K47/6863
    • The present invention provides an immunoconjugate formulation that is substantially free of particles, the immunoconjugate formulation comprising: an immunoconjugate and one or more excipients selected from the group consisting of: sucrose, polysorbate 20, polysorbate 80, cyclodextrin, dextrose, glycerol, polyethylene glycol, mannitol, sodium chloride, and an amino acid, wherein the formulation is a buffered aqueous solution having a pH of 4.5 to 7.6. The present invention also provides an immunoconjugate formulation that is substantially free of aggregates, the immunoconjugate formulation comprising: an immunoconjugate and one or more excipients selected from the group consisting of histidine, sucrose, glycine and sodium chloride, wherein the formulation is a buffered aqueous solution having a pH of 4.5 to 7.6. The present invention further provides an immunoconjugate formulation that is substantially free of both particles and aggregates.
    • 本发明提供了基本上不含颗粒的免疫偶联物制剂,所述免疫偶联物制剂包含:免疫偶联物和一种或多种选自以下的赋形剂:蔗糖,聚山梨醇酯20,聚山梨醇酯80,环糊精,右旋糖,甘油,聚乙二醇, 甘露醇,氯化钠和氨基酸,其中所述制剂是pH为4.5至7.6的缓冲水溶液。 本发明还提供了基本上不含聚集体的免疫缀合物制剂,免疫缀合物制剂包含:免疫偶联物和一种或多种选自组氨酸,蔗糖,甘氨酸和氯化钠的赋形剂,其中所述制剂是缓冲水溶液 pH为4.5至7.6。 本发明还提供基本上不含颗粒和聚集体的免疫偶联物制剂。